Weekly Recap: Eighth Circuit upholds Roundup and Kerendia Japan filingTradingView·14 hours agoBAYRY+1.60%BAYN
Bayer announces presentation of results from Phase III REVEAL studybusinessinsider·16 hours agoBAYRY+1.60%BAYN
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026 | BAYRY Stock NewsStockTitan·1 day ago, 10:45 PMBAYRY+1.60%BAYN
Bayer's $7.25 Billion Roundup Plan Survives Another Court DetourGuruFocus·Aug 28 at 12:59 PMBAYRY+1.60%BAYN
Bayer, Pharmacity partner with VINAFPA on reproductive health educationvnexpress·Aug 26 at 11:06 PMBAYRY+1.60%BAYN
Sabanto Appoints Agriculture Technology Veteran John M. Raines to its Board of Directors | FMC Stock NewsStockTitan·Aug 25 at 11:07 PMFMC+2.07%BAYN
MustGrow Receives First Milestone Payment from Bayer AG | MGROF Stock NewsStockTitan·Aug 20 at 10:00 PMBAYRY+1.60%BAYN
Is Bayer (XTRA:BAYN) Still Undervalued After Its Health Canada Approval?Simplywall·Aug 19 at 02:42 AMBAYRY+1.60%BAYN
Evogene Q2 2026 Earnings: Net Loss Narrows Despite Lower RevenueTradingKey·Aug 18 at 07:16 AMEVGN-3.82%BAYN
